20 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Studio randomizzato

Assessing the clinical- and cost-effectiveness of REFUEL-MS, a digital therapeutic for multiple sclerosis-related fatigue: study protocol for a randomised controlled trial.

Sophie Fawson, Harriet Mortimer, Alya Abouzahr, Hannah Proudfoot, Ereza Ibrahimi, Nicole Dodsworth, Tara Jackson, Madison Milne-Ives, REFUEL-M. S. Patient Advisory Group, Tom Sanders, Tracy Finch, Sarah Thomas, Jennifer Freeman, Marietta L van der Linden, Tom Mercer, Victoria Williams, Barbara Barrett, Sam Norton, Rona Moss-Morris

Trials · 2026

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansMultiple SclerosisFatigueCost-Benefit AnalysisEquivalence Trials as TopicTreatment OutcomeCognitive Behavioral TherapyUnited KingdomRandomized Controlled Trials as TopicCost-Effectiveness AnalysisQuality of LifeMobile ApplicationsAdultHealth Care CostsDigital interventionMultiple sclerosisRandomised controlled trial

Come citare questo studio

Sophie Fawson, Harriet Mortimer, Alya Abouzahr, Hannah Proudfoot, Ereza Ibrahimi, Nicole Dodsworth, Tara Jackson, Madison Milne-Ives, REFUEL-M. S. Patient Advisory Group, Tom Sanders, Tracy Finch, Sarah Thomas, Jennifer Freeman, Marietta L van der Linden, Tom Mercer, Victoria Williams, Barbara Barrett, Sam Norton, Rona Moss-Morris. (2026). Assessing the clinical- and cost-effectiveness of REFUEL-MS, a digital therapeutic for multiple sclerosis-related fatigue: study protocol for a randomised controlled trial.. Trials. DOI: 10.1186/s13063-026-09925-8

Consulta la pubblicazione originale ↗